How it should be taken
It comes as an intravenous single use injection vials.
Dosage & When it is to be taken
The recommended dosage is 50 kBq (1.35 microcurie) per kg body weight, given at 4 week intervals for 6 injections.
When it is not to be taken (Contraindications)
Contraindicated in women who are pregnant.
Why it is prescribed (Indications)
This medication is an alpha particle-emitting radioactive therapeutic agent indicated for treatment of patients with metastatic castration-resistant prostate cancer (mCRPC), symptomatic bone metastases and no known visceral metastatic disease.
Warnings and Precautions
Caution is needed in patients who have bone marrow problems. This medication can cause blood cell counts to go down and result in bone marrow suppression.
Caution is needed in women who are planning to become pregnant, nursing mothers and pediatric. Safety and efficacy have not been established for these people.
Store at room temperature below 40° C (104° F) in the original container or equivalent radiation shielding.